Search
Search Funnelback University
- Refined by:
- Date: 2023
Your query has been expanded to `news stories` |u:www.enterprize.cam.ac.uk. Search for `news stories` |u:www.enterprise.cam.ac.uk instead.
81 -
100 of
173
search results for `news stories` |u:www.enterprise.cam.ac.uk or `news stories` |u:www.enterprize.cam.ac.uk
Fully-matching results
-
CellCentric raises $26m to take first-in-class p300/CBP inhibitor…
https://www.enterprise.cam.ac.uk/news/cellcentric-raises-26-million-to-take-first-in-class-p300cbp-inhibitor-into-the-clinic/22 Feb 2023: CellCentric has raised $26 million in private financing to fund clinical testing of its first-in-class oncology drug candidate CCS1477. The funds will be used to test the novel p300/CBP inhibitor in late stage, treatment-resistant prostate cancer. -
University spin-out Xampla names sustainability leader to board –…
https://www.enterprise.cam.ac.uk/news/university-spin-out-xampla-names-sustainability-leader-to-board/23 Feb 2023: the news of Xampla’s continued success. Xampla originated at Cambridge University and we continue. -
Gone fishing: highly accurate test for common respiratory viruses…
https://www.enterprise.cam.ac.uk/news/gone-fishing-highly-accurate-test-for-common-respiratory-viruses-uses-dna-as-bait/17 Jan 2023: Cambridge researchers have developed a new test that ‘fishes’ for multiple respiratory viruses at once using single strands of DNA as ‘bait’, and gives highly accurate results in under an hour. -
University of Cambridge breaks its early stage investment record for…
https://www.enterprise.cam.ac.uk/news/university-of-cambridge-breaks-its-early-stage-investment-record-for-the-fourth-consecutive-year/22 Feb 2023: The University of Cambridge has broken its early stage investment record, approving 14 seed fund investments for a total of £5.3 million. Read more here. -
Qkine raises £1.5m series A funding – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-qkine-secures-1-5m-series-a-funding-to-accelerate-global-scale-up/22 Feb 2023: Qkine, a Cambridge spin-out, raises £1.5m series A investment round to accelerate the global scale-up of its commercial operations. -
DefiniGEN Licenses Lung Stem Cell Technology from University of…
https://www.enterprise.cam.ac.uk/news/definigen-licences-lung-stem-cell-technology-from-university-of-cambridge/22 Feb 2023: DefiniGEN Ltd announced that it has strengthened its IP portfolio with a licence for lung stem cell technology from the University of Cambridge. Read more. -
Habitat for Humanity: Protecting communities against flood risk –…
https://www.enterprise.cam.ac.uk/case-studies/habitat-for-humanity-protecting-communities-against-flood-risk/27 Jul 2023: Recognising the need to understand risk and to build resilience globally, Habitat for Humanity have been working with the University of Cambridge... -
Cytora receives investment led by the University of Cambridge
https://www.enterprise.cam.ac.uk/news/geopolitical-risk-analytics-start-up-cytora-receives-investment-led-by-the-university-of-cambridge/22 Feb 2023: Cytora, a pioneer in event detection, whose technology is deployed globally, has raised a second round of investment led by Cambridge Enterprise... -
TenU university TTOs welcome the UK Government’s Independent Review…
https://www.enterprise.cam.ac.uk/news/tenu-university-ttos-welcome-the-uk-governments-independent-review-of-university-spin-out-companies/21 Nov 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 21 November 2023. TenU university TTOs welcome the UK Government’s Independent Review of University Spin-out Companies. Share:. TenU, the international collaboration of ten technology -
How we use your personal information - job applicants – Cambridge…
https://www.enterprise.cam.ac.uk/privacy-compliance/data-protection/privacy-job-applicants/13 Dec 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – job applicants. How we use your personal information – job applicants. This policy explains what personal information is provided by job -
Cambridge remains most intensive science and technological cluster in …
https://www.enterprise.cam.ac.uk/news/cambridge-remains-most-intensive-science-and-technological-cluster-in-the-world/22 Sep 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 21 September 2023. Cambridge remains most intensive science and technological cluster in the world. Share:. Cambridge remains the most intensive science and technological cluster in the -
Cambridge spin-out Nyobolt raises £50m to lead the future of…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-nyobolt-raises-50m-to-lead-the-future-of-sustainable-energy-storage/15 Mar 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 15 July 2022. Cambridge spin-out Nyobolt raises £50m to lead the future of sustainable energy storage. Share:. the pioneers of end-to-end fast-charging battery systems, announce today -
‘Biohybrid’ device could restore function in paralysed limbs –…
https://www.enterprise.cam.ac.uk/news/biohybrid-device-could-restore-function-in-paralysed-limbs/23 Mar 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 22 March 2023. ‘Biohybrid’ device could restore function in paralysed limbs. Share:. Researchers have developed a new type of neural implant that could restore limb function to -
Cambridge researcher gets green light for while-you-wait Hep B test – …
https://www.enterprise.cam.ac.uk/news/cambridge-researcher-gets-green-light-for-while-you-wait-hep-b-test/22 Feb 2023: said: “Approval of the new Hepatitis B Rapid Test is positive news for the estimated 400 million HBV carriers worldwide.”. -
How we use your personal information - Experts & Mentors –…
https://www.enterprise.cam.ac.uk/privacy-compliance/data-protection/privacy-experts-mentors/1 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – Experts & Mentors. How we use your personal information – Experts & Mentors. This policy is intended to assist you in making an informed -
Leading universities and VCs publish unique USIT Guide to accelerate…
https://www.enterprise.cam.ac.uk/news/leading-universities-and-vcs-publish-unique-usit-guide-to-accelerate-university-spin-outs-and-boost-uk-growth-2/19 May 2023: As it stands, many of these deals are created from scratch, which is both inefficient and sometimes fails to learn the lessons from previous success stories. -
Four top universities bring inventors and industry together for…
https://www.enterprise.cam.ac.uk/news/four-top-universities-bring-inventors-and-industry-together-for-two-day-event/22 Sep 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 22 September 2023. Four top universities bring inventors and industry together for two-day event. Share:. Industry specialists from across the continent came together to discover new -
Cambridge spin-out PredictImmune announces new US patent – Cambridge…
https://www.enterprise.cam.ac.uk/news/spin-predictimmune-announces-new-us-patent/22 Feb 2023: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today confirmed its latest patent... -
Impossible Materials closes CHF 3.4m seed round to accelerate market…
https://www.enterprise.cam.ac.uk/news/impossible-materials-closes-chf-3-4m-seed-round-to-accelerate-market-entry/5 Apr 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 5 April 2023. Impossible Materials closes CHF 3.4m seed round to accelerate market entry. Share:. Impossible Materials Ltd. in Marly (Switzerland) secures CHF 3.4m from an -
Cambridge joins consortium to launch £40 million Apollo fund to drive …
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-joins-consortium-world-leading-uk-universities-global-pharmaceutical-companies-launch-40-million-fund-drive-therapeutic-innovation/22 Feb 2023: Three global pharmaceutical companies and the technology transfer offices of three world-leading universities have joined forces to create the Apollo Therapeutics Fund.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.